ECOG2205: A phase Ⅱ study to measure response rate and toxicity of neo-adjuvant chemoradiotherapy (CRT) ( IMRT permitted)with oxaliplatin (O) and infusional 5-fluorouracil ( 5-FU ) plus eetuximab ( C225 ) followed by postoperative docetaxel (DT) and C in patients with operable adenocarcinoma of the esophagus : high risk of post-op adult respriratory distress syndrome(ARDS)

查看全文 作　　者：Kleinberg LR; Catalano PJ; Gibson CA; 出　　处：《J Clin Oncol》索引2010年第78卷第3期,共0页